Chipscreen(SH:688321) Zheng Quan Zhi Xing·2025-08-22 10:18Core Viewpoint - Shenzhen Micu Biotechnology Co., Ltd. has received acceptance from the Shanghai Stock Exchange for its application to issue A-shares to specific investors, marking a significant step in its capital raising efforts [1][2]. Group 1: Company Announcement - The company announced that it received a notification from the Shanghai Stock Exchange on August 22, 2025, regarding the acceptance of its securities issuance application [1]. - The application documents were verified to be complete and in compliance with legal requirements, leading to the decision for acceptance and review by the exchange [1]. - The issuance of A-shares is subject to further review by the Shanghai Stock Exchange and approval from the China Securities Regulatory Commission, indicating that the process is not yet finalized [1]. Group 2: Regulatory Process - The company will keep investors informed about the progress of the application and any developments related to the review and approval process [1].